Prenatal Use of Epilepsy Drug Tied to Autism Risk
Large Danish study looked at children of women who took valproate in pregnancy
WebMD News Archive
What's most important is that women understand the risks and benefits of any drug they're being given, Meador said.
"This is not a minor thing. Doctors should tell women what the risks are. And, this shouldn't be something you just think about when you're planning a pregnancy, because about half of all pregnancies in the U.S. are unplanned. The time to talk about medications is before pregnancy, and medications should be used in the lowest dose possible to control seizures," said Meador, who added, "My approach is to start with other drugs first."
However, study author Christensen said, "A number of women of childbearing potential may only become seizure-free when treated with valproate. Seizures during pregnancy may have serious effects on both the mother and the unborn child. Therefore, the doctors and pregnant women will have to balance the risk associated with seizures during pregnancy with the risk of congenital malformations and other potential adverse outcomes in the exposed children. In addition, not all pregnancies are planned and therefore, some children may unintentionally be exposed to valproate."
He noted that the use of valproate in women of childbearing years has gone down in recent years, but because of the reasons he mentioned, there will likely always be some women in their childbearing years taking the drug.
Both Christensen and Meador said they believe that valproate might increase the risk of autism and autism spectrum disorders by altering the development of nerve cells in the brain. The drug doesn't necessarily destroy the developing cells, but changes them in a way that makes it harder for the cells to work and communicate with each other the way they're supposed to.
Although the study tied the use of valproate in pregnancy to higher autism risk in children, it did not establish a cause-and-effect relationship.